Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Base Sequence × Clear all

Status

Unknown 3 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Radiation Injuries 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Head and Neck Neoplasms 1 Cholangiocarcinoma 1 Cervical Cancer Susceptible Population Classification 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡